<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6423905/results/search/drugs/results.xml">
  <result pre="former prodromal symptoms reflect dopaminergic hypersensitivity and are mediated by" exact="nitric oxide" post="pathways ( 42). Del Zompo et al. have shown"/>
  <result pre="susceptibility to migraine, at least in some migraine patients, and" exact="dopamine" post="can play a key role in activating the biochemical"/>
  <result pre="( 51) or brainstem may persist after headache relief by" exact="sumatriptan" post="( 52), lending support to the hypothesis that some"/>
  <result pre="in children and adults ( 66), including increased levels of" exact="calcitonin" post="gene-related peptide ( 67), decreased levels of coenzyme Q"/>
  <result pre="statement are scarce but the efficacy in migraine prevention of" exact="naratriptan" post="and dopamine antagonists is suggested by nonrandomized trials ("/>
  <result pre="scarce but the efficacy in migraine prevention of naratriptan and" exact="dopamine" post="antagonists is suggested by nonrandomized trials ( 75, 76)."/>
  <result pre="placebo-controlled, randomized trials to ascertain this hypothesis. Similarly, domperidone, a" exact="dopamine" post="antagonist, may block a migraine attack, provided it is"/>
  <result pre="adolescents. It has been shown, in adult migraine sufferers, that" exact="nitroglycerin" post="and pituitary adenylate-cyclase activating protein could induce postdromal symptoms,"/>
  <result pre="M Bocchetta A Gessa GL et al. . Association between" exact="dopamine" post="receptor genes and migraine without aura in a Sardinian"/>
  <result pre="Chang SH Lee WT Wu RM Chiou LC . Plasma" exact="calcitonin" post="gene-related peptide in diagnosing and predicting paediatric migraine. Cephalalgia."/>
 </snippets>
</snippetsTree>
